SHAUNA WHATCOTT-SCLAFANI: Open Payments
NPI 1174633408 · PROVO, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,740 in 82 payments from 15 companies in 2025. Trend: 2023 $1,820 · 2024 $2,209 · 2025 $1,740
Food & beverage: $1,726Education: $14
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 22 | $359 |
| Alnylam Pharmaceuticals Inc. | 4 | $237 |
| Merck Sharp & Dohme LLC | 12 | $224 |
| Amgen Inc. | 10 | $182 |
| Novo Nordisk Inc | 5 | $146 |
| Novartis Pharmaceuticals Corporation | 6 | $130 |
| Actelion Pharmaceuticals US, Inc. | 5 | $112 |
| E.R. Squibb & Sons, L.L.C. | 4 | $84 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $76 |
| Inspire Medical Systems, Inc. | 3 | $44 |
Products named: AMVUTTRA, VYNDAQEL, ELIQUIS, REPATHA, VERQUVO, Wegovy, UPTRAVI, LEQVIO.
Industry payments across UT — which companies pay providers there.
